A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg

NCT00219115 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
493
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis